908 Devices (MASS) Stock Analysis & AI Equity Report

Medical - Devices USD Explore free reports

908 Devices (MASS) overview

908 Devices (MASS) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 56.2m and operating profit of USD -39.4m; the year-end share price was 5.25 USD and market capitalisation was USD 191m. 908 Devices is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get 908 Devices's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 144mFY 2025
Share price5.25 USDFY 2025 year end
RevenueUSD 56.2mFY 2025
Operating profitUSD -39.4mFY 2025
Net earningsUSD 19.5mFY 2025
Market capitalisationUSD 191mFY 2025 year end

About 908 Devices

908 Devices develops handheld instruments for chemical analysis at the point of need. Its products combine mass spectrometry, optical spectroscopy, analytics and machine learning to identify materials and provide rapid results in health, safety and defense applications. The company’s devices are used by front-line workers and government agencies, including to detect illicit drugs, counterfeit pharmaceuticals and hazardous substances in air or on surfaces.

Generate the 908 Devices report

908 Devices is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for 908 Devices and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on 908 Devices

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.